CClinicalTrials.gg
CompletedNCT01940874Co-HLMUpdated Oct 9, 2013

Cerebral Oxymetry at Elective Coronary and Valve Surgery.

An observational study in Coronary Artery Disease., Aortic Valve Stenosis. and Aortic Valve Regurgitation., sponsored by Oslo University Hospital. Completed at 1 site in Norway. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2013-10-09.

Sponsored by Oslo University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
54
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Use of vasopressor to maintain Mean Arterial Pressure on Cardio Pulmonary Bypass can lead to decreased cerebral flow and oxygenation in individual patients and this can be detected by means of cerebral oxymetry.

02

Conditions studied

  • Coronary Artery Disease.
  • Aortic Valve Stenosis.
  • Aortic Valve Regurgitation.

Keywords

  • Cerebral Oximetry.
  • Aortic valve stenosis.
  • Aortic valve regurgitation.
  • Coronary artery disease.
03

In context

Coronary Artery Disease

5,596 studies on the registry are indexed under Coronary Artery Disease; 955 are open to participants now.

This study's enrollment of 54 is below the median of 336 across 1,946 observational studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

We want to include 50 patients, both women and men, undergo elective coronary bypass surgery or valve surgeon in CPB with moderate hypothermia.

Inclusion criteria

  • Patient age under 80.
  • Patients should undergo elective coronary artery bypass grafting surgery (ACB) or heart valve surgery (AVR or MVR).
  • The patient must be admitted at least 18 years of years.

Exclusion criteria

Exclusion Criteria:

  • Damage to the frontal lobes corresponding to the area where SCO2 monitored.
  • Patients in pharmacological studies.
  • Patients with known intracranial vascular anomalies or cerebral aneurysms.
  • Patients with known neurological disease.
  • Patients with known undergone cerebral insult, TIA or carotid stenosis.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
54 participants (actual)
Patient registry
No

Groups and cohorts

  • Cerebral oximetry
06

What researchers measure

Primary outcomes

  1. Cerebral oxymetry values

    Time frame: March 2013

07

Study locations

1 site
  • Oslo University Hospital
    Oslo, 0424, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 9, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01940874
Lead sponsor
Oslo University Hospital
Responsible party
Sponsor
First posted
Sep 12, 2013
Start date
Feb 2011
Primary completion
Mar 2013
Completion
Mar 2013
Last update
Oct 9, 2013

Study contacts

Ove A. Hagen, MD
principal investigator · Oslo Ùniversity Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion